Acalabrutinib Versus Idelalisib Plus Rituximab (IdR) or Bendamustine Plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ghia, Paolo | - |
dc.contributor.author | Pluta, Andrzej | - |
dc.contributor.author | Wach, Malgorzata | - |
dc.contributor.author | Lysak, Daniel | - |
dc.contributor.author | Kozak, Tomas | - |
dc.contributor.author | Simkovic, Martin | - |
dc.contributor.author | Kaplan, Polina | - |
dc.contributor.author | Kraychok, Iryna | - |
dc.contributor.author | Illes, Arpad | - |
dc.contributor.author | de la Serna, Javier | - |
dc.contributor.author | Dolan, Sean | - |
dc.contributor.author | Campbell, Philip | - |
dc.contributor.author | Musuraca, Gerardo | - |
dc.contributor.author | Jacob, Abraham | - |
dc.contributor.author | Avery, Eric J. | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.contributor.author | Wang, Denise | - |
dc.contributor.author | Patel, Priti | - |
dc.contributor.author | Jurczak, Wojciech | - |
dc.date.available | 2020-09-16T01:35:30Z | - |
dc.date.created | 2020-09-16 | - |
dc.date.issued | 2020-09 | - |
dc.identifier.issn | 2152-2650 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/78219 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | CIG MEDIA GROUP, LP | - |
dc.relation.isPartOf | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - |
dc.title | Acalabrutinib Versus Idelalisib Plus Rituximab (IdR) or Bendamustine Plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000564055100161 | - |
dc.identifier.bibliographicCitation | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.20, pp.S220 - S221 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | S221 | - |
dc.citation.startPage | S220 | - |
dc.citation.title | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - |
dc.citation.volume | 20 | - |
dc.contributor.affiliatedAuthor | Lee, Jae Hoon | - |
dc.type.docType | Meeting Abstract | - |
dc.subject.keywordAuthor | CLL | - |
dc.subject.keywordAuthor | chronic lymphocytic leukemia | - |
dc.subject.keywordAuthor | phase 3 | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.description.journalRegisteredClass | scie | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.